ALMEX — Mexedia SpA SB Income Statement
0.000.00%
- €16.53m
- €13.19m
- €72.90m
- 28
- 71
- 15
- 27
Annual income statement for Mexedia SpA SB, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 134 | 132 | 141 | 324 | 72.9 |
Cost of Revenue | |||||
Gross Profit | 5.23 | 10.2 | 11.8 | 22.2 | 7.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 129 | 125 | 133 | 311 | 97.6 |
Operating Profit | 5.23 | 6.89 | 8.36 | 12.8 | -24.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.92 | 3.44 | 4.95 | 6.48 | -27.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.95 | 2.96 | 4.43 | 4.47 | -26.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3.95 | 2.96 | 4.43 | 4.47 | -20 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.95 | 2.96 | 4.43 | 4.47 | -20 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.692 | 0.519 | 0.778 | 0.784 | -3.51 |